Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, offering promising developments throughout various medical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, much more trusted substitute for therapeutic use, specia